Novasys Medical takes $49.5M for women’s medical device
Novasys Medical is a Newark, Calif. medical company that makes a device for a specific condition affecting some women, called female stress urinary incontinence.
The device Novasys makes is the only real alternative to surgery for women with the problem, according to an interview with the CEO in VentureWire, which also reported the funding.
The $49.5 million was led by Versant Ventures, with participation from Skyline Ventures, Three Arch Partners, Affinity Capital Management, Alloy Ventures, Delphi Ventures, GBS Venture Partners, Invesco Private Capital, JP Morgan Partners and Onset Ventures.
Next Story: iPhone expansion continues: Europe, Mideast, Africa, Atlantis…
Previous Story: WPP is very happy about its Yahoo partnership — would be happier if it included Microsoft as well
Tags: co:novasys medical, deal, inv:Affinity-Capital-Management, inv:Alloy-Ventures, inv:Delphi-Ventures, inv:GBS-Venture-Partners, inv:Invesco-Private-Capital, inv:JP-Morgan-Partners, inv:ONSET-Ventures, inv:Skyline-Ventures, inv:Three-Arch-Partners
About the Author, Chris Morrison
Chris Morrison writes about cleantech and environmental issues for VentureBeat, with occasional forays into gaming and semantic technology. He got his start writing about tech for Business 2.0 magazine, but quickly realized new media was the ticket when that institution closed its doors in 2007. Chris has also covered public equities and regulatory issues. He originally hails from southern Virginia, graduated from Evergreen State College in Washington, and now lives in San Francisco.
VentureBeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, GamesBeat
- Anthony Ha, Assistant Editor, VentureBeat
- Camille Ricketts, Lead Writer, GreenBeat
- Paul Boutin, Writer, VentureBeat
- Kim-Mai Cutler, Writer, VentureBeat
- Matthaus Krzykowski, Mobile Consultant & Coordinator
VentureBeat Start-Up Index
An index of the hottest startups, measured by trends in their traffic, news coverage, buzz and funding.